United States Insulin Pen Market is expected to reach more than US$2.5 Billion by 2022.  Market growth can be attributed to factors such as diabetes patient population, user–friendly design, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs and technological advancements in the field of insulin pen devices. However, low patient awareness,